C. Frank Bennett, SVP, Antisense Research at IONIS PHARMACEUTICALS INC (IONS), sold 18,026 shares at $58.29 ($1.1M) on 2019-02-01, disclosed to the SEC on 2019-02-05.
Open-market sale of $1.1M IONS by SVP, Antisense Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.29 | 9,013 | $525K | 50.0% |
| 2 | $58.29 | 9,013 | $525K | 50.0% |
| Total | $58.29 avg | 18,026 | $1.1M | 100% |
| Filing → |
| IONS | SELL | 2026-02-04 | $14.1M | — | Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |